Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma.
Haeno T, Rai S, Miyake Y, Inoue M, Fujimoto K, Fujii A, Iwata Y, Minamoto S, Taniguchi T, Kakutani H, Inoue H, Kumode T, Serizawa K, Taniguchi Y, Hirase C, Morita Y, Tanaka H, Tatsumi Y, Ashida T, Matsumura I. Haeno T, et al. Among authors: kakutani h. J Clin Exp Hematop. 2023 Jun 28;63(2):99-107. doi: 10.3960/jslrt.23001. Epub 2023 Apr 28. J Clin Exp Hematop. 2023. PMID: 37121716 Free PMC article.
Epstein-Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-immunotherapy.
Inoue H, Rai S, Tanaka H, Espinoza JL, Komori-Inoue M, Kakutani H, Minamoto S, Kumode T, Nakayama S, Taniguchi Y, Morita Y, Okuda T, Tatsumi Y, Ashida T, Matsumura I. Inoue H, et al. Among authors: kakutani h. Viruses. 2020 Apr 8;12(4):416. doi: 10.3390/v12040416. Viruses. 2020. PMID: 32276450 Free PMC article.
Targeted therapy for medullary and extramedullary relapse of FLT3-ITD acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
Kumode T, Rai S, Tanaka H, Espinoza JL, Kakutani H, Watatani Y, Minamoto S, Taniguchi Y, Nakayama S, Morita Y, Ashida T, Matsumura I. Kumode T, et al. Among authors: kakutani h. Leuk Res Rep. 2020 Aug 7;14:100219. doi: 10.1016/j.lrr.2020.100219. eCollection 2020. Leuk Res Rep. 2020. PMID: 32817816 Free PMC article.
CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence.
Serizawa K, Tanaka H, Ueda T, Fukui A, Kakutani H, Taniguchi T, Inoue H, Kumode T, Taniguchi Y, Rai S, Hirase C, Morita Y, Espinoza JL, Tatsumi Y, Ashida T, Matsumura I. Serizawa K, et al. Among authors: kakutani h. Int J Hematol. 2022 Mar;115(3):336-349. doi: 10.1007/s12185-021-03261-0. Epub 2022 Feb 8. Int J Hematol. 2022. PMID: 35133572
CD34+ and CD34- MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34+ MM cells.
Fukui-Morimoto A, Serizawa K, Fujimoto K, Hanamoto A, Iwata Y, Kakutani H, Kumode T, Hirase C, Morita Y, Tatsumi Y, Hanamoto H, Tanaka H, Matsumura I. Fukui-Morimoto A, et al. Among authors: kakutani h. Int J Hematol. 2024 Nov 12. doi: 10.1007/s12185-024-03867-0. Online ahead of print. Int J Hematol. 2024. PMID: 39531203
The Elental® elemental diet for chemoradiotherapy-induced oral mucositis: A prospective study in patients with oral squamous cell carcinoma.
Harada K, Minami H, Ferdous T, Kato Y, Umeda H, Horinaga D, Uchida K, Park SC, Hanazawa H, Takahashi S, Ohota M, Matsumoto H, Maruta J, Kakutani H, Aritomi S, Shibuya K, Mishima K. Harada K, et al. Among authors: kakutani h. Mol Clin Oncol. 2019 Jan;10(1):159-167. doi: 10.3892/mco.2018.1769. Epub 2018 Nov 16. Mol Clin Oncol. 2019. PMID: 30655992 Free PMC article.
66 results